OMCL * Stock Overview
Provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Omnicell, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$886.00 |
| 52 Week High | US$886.00 |
| 52 Week Low | US$886.00 |
| Beta | 0.82 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -76.26% |
| 5 Year Change | n/a |
| Change since IPO | -66.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| OMCL * | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how OMCL * performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how OMCL * performed against the MX Market.
Price Volatility
| OMCL * volatility | |
|---|---|
| OMCL * Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: OMCL *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine OMCL *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 3,660 | Randy Lipps | www.omnicell.com |
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software.
Omnicell, Inc. Fundamentals Summary
| OMCL * fundamental statistics | |
|---|---|
| Market cap | Mex$43.83b |
| Earnings (TTM) | -Mex$364.15m |
| Revenue (TTM) | Mex$21.91b |
2.0x
P/S Ratio-120.4x
P/E RatioIs OMCL * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OMCL * income statement (TTM) | |
|---|---|
| Revenue | US$1.06b |
| Cost of Revenue | US$623.24m |
| Gross Profit | US$440.97m |
| Other Expenses | US$458.66m |
| Earnings | -US$17.69m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.38 |
| Gross Margin | 41.44% |
| Net Profit Margin | -1.66% |
| Debt/Equity Ratio | 46.5% |
How did OMCL * perform over the long term?
See historical performance and comparison